Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • niel
    Junior Member
    • Feb 2014
    • 4

    edgeR issue:RNA seq

    I am facing an error at the step Trended Dispersion, although no error during Common dispersion estimation.

    rownames(design) <- colnames (d)
    > z<- estimateGLMCommonDisp(d , design)
    v<- estimateGLMTrendedDisp(d , design)
    Error in t(y) + prior.count.scaled : non-conformable arrays

    Please suggest what could be the reason, and what would be the way out.
  • niel
    Junior Member
    • Feb 2014
    • 4

    #2
    do I have to edit aveLogCPM.default, if yes, then How?

    Comment

    • bruce01
      Senior Member
      • Mar 2011
      • 160

      #3
      I think

      v<- estimateGLMTrendedDisp(d , design)

      should be

      v<- estimateGLMTrendedDisp(z , design)

      ie you have to run CommonDisp on 'd', and then run TrendedDisp on the output of that.

      Comment

      • niel
        Junior Member
        • Feb 2014
        • 4

        #4
        Ok.. yah.. Thanks. I was making some silly input mistake in some earlier step too. That step, including your suggession make it work properly. But strangely, all 20 top tags are showing Downregulation in disease. That has made me a bit sceptical. I am doing double check now.

        Thanks

        Comment

        • bruce01
          Senior Member
          • Mar 2011
          • 160

          #5
          Good that it works; to check your top 20 tags I suggest you look at FPKM/RPKM or raw counts to make sure the 'direction' of regulation is correct. EdgeR gives "-logFC" for the first condition you provide IIRC. This can be confusing, and I still double check all results against FPKMs.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...